I am a life science executive with a passion for introducing new technologies with potential to transform human health. I've spent my career in diagnostics, working on both IVDs and LDTs. I joined the founding team at Truvian in late 2015 to work on development of a disruptive benchtop blood testing solution for the point of care. At Truvian, we are working to reimagine blood testing - making it more convenient, affordable, and actionable for patients. As Chief Operating Officer, I oversee portfolio management, business operations, manufacturing, technical operations, assay development, clinical development, scientific affairs, and talent & HR.Prior to Truvian, I co-founded Epic Sciences, a liquid biopsy company. During my tenure as Epic’s Chief Scientific Officer, I established and ran the Pharma Parntering business, assay development, and laboratory operations (CLIA lab). Our work resulted in the launch of a prostate cancer test which was commercialized by Genomic Health (Exact) in 2015.  In addition to my role at Truvian, I serve as a board member on the Executive Committee for Connect.org as well as an advisor for various biotech start-ups.  I was named as the Top 10 Fiercest Women in Life Sciences by Fierce Pharma in 2023, MIT Technology Review's Top 35 Innovators Under 35, Foreign Policy's Top 100 Leading Global Thinkers, and the PharmaVoice 100. I also was named a Life Science Catalyst Award winner, gaining recognition from Biocom and San Diego Venture Group as one of 10 individuals sparking meaningful change to human health. I have authored dozens of peer reviewed publications and am an inventor on >30 patents. I hold a B.S. in Chemistry from University of Vermont and a Ph.D. from The Scripps Research Institute in Chemical Biology.